Literature DB >> 22137224

Ocular and oral mucous membrane pemphigoid (cicatricial pemphigoid).

Lawrence S Chan1.   

Abstract

Mucous membrane pemphigoid, a heterogeneous group of autoimmune blistering diseases, affects primarily the mucous membranes. Although oral and ocular mucosae can both be affected in a given patient, patients with involvement restricted to oral mucosae tend to have a benign outcome, whereas those with ocular disease commonly face treatment resistance, resulting in scarring and blindness. Diagnosis requires direct immunofluorescence microscopy to demonstrate a linear deposition of immunoglobulin (Ig) G or IgA, or complement component 3 (C3), at the epithelial basement membrane. Although the target antigens vary, subsets of patients affected exclusively by oral and ocular mucosal diseases have autoantibodies targeting α-6 and β-4 integrins, respectively.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22137224     DOI: 10.1016/j.clindermatol.2011.03.007

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  19 in total

1.  Clinical features and in vivo confocal microscopy assessment in 12 patients with ocular cicatricial pemphigoid.

Authors:  Qin Long; Ya-Gang Zuo; Xue Yang; Ting-Ting Gao; Jie Liu; Ying Li
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

Review 2.  Ocular mucous membrane pemphigoid: a review.

Authors:  Samanta Taurone; Marialuisa Spoletini; Massimo Ralli; Pietro Gobbi; Marco Artico; Laszlò Imre; Cecília Czakò; Illés Kovàcs; Antonio Greco; Alessandra Micera
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

Review 3.  Vegetating erosive cutaneous lesions and pyogenic granuloma in the course of mucous membrane pemphigoid: a case report and review of literature.

Authors:  Beata Jakubowska; Cezary Kowalewski; Norito Ishii; Takashi Hashimoto; Katarzyna Wozniak
Journal:  Int Wound J       Date:  2018-06-29       Impact factor: 3.315

Review 4.  Oral manifestations of systemic disease.

Authors:  S R Porter; V Mercadante; S Fedele
Journal:  Br Dent J       Date:  2017-11-10       Impact factor: 1.626

5.  Limbal Fibroblasts Maintain Normal Phenotype in 3D RAFT Tissue Equivalents Suggesting Potential for Safe Clinical Use in Treatment of Ocular Surface Failure.

Authors:  Isobel Massie; Sarah B Dale; Julie T Daniels
Journal:  Tissue Eng Part C Methods       Date:  2014-12-17       Impact factor: 3.056

6.  A gene network bioinformatics analysis for pemphigoid autoimmune blistering diseases.

Authors:  Antonio Barone; Paolo Toti; Maria Rita Giuca; Giacomo Derchi; Ugo Covani
Journal:  Clin Oral Investig       Date:  2014-11-08       Impact factor: 3.573

7.  Aldehyde dehydrogenase inhibition blocks mucosal fibrosis in human and mouse ocular scarring.

Authors:  Sarah D Ahadome; David J Abraham; Suryanarayana Rayapureddi; Valerie P Saw; Daniel R Saban; Virginia L Calder; Jill T Norman; Markella Ponticos; Julie T Daniels; John K Dart
Journal:  JCI Insight       Date:  2016-08-04

8.  Monoclonal anti-CD20 Antibody Therapy in Cicatrical Pemphigoid with Oral and Hypopharyngeal Involvement and Related Conditions.

Authors:  Uwe Wollina; Friedemann Pabst; Heidrun Kuss; Michaela Tilp; Juliane Runge
Journal:  J Clin Aesthet Dermatol       Date:  2013-05

9.  Oral mucocutaneous lesions - a comparative clinicopathological and immunofluorescence study.

Authors:  Annasamy Rameshkumar; Alex Kumaranthara Varghese; Thayalan Dineshkumar; Shaheen Ahmed; Janaki Venkatramani; G Sugirtharaj
Journal:  J Int Oral Health       Date:  2015-03

Review 10.  Clinical relevance of autoantibodies in patients with autoimmune bullous dermatosis.

Authors:  Lilla Mihályi; Mária Kiss; Attila Dobozy; Lajos Kemény; Sándor Husz
Journal:  Clin Dev Immunol       Date:  2012-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.